Endoscopic Treatment of Gastroesophageal Reflux Disease


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Herman R.M.
        • Berho M.
        • Murawski M.
        • et al.
        Defining the histopathological changes induced by nonablative radiofrequency treatment of faecal incontinence—a blinded assessment in an animal model.
        Colorectal Dis. 2015; 17: 433-440
        • Utley D.S.
        • Kim M.
        • Vierra M.A.
        • et al.
        Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a procine model.
        Gastrointest Endosc. 2000; 52: 81-86
        • Kim M.S.
        • Holloway R.H.
        • Dent J.
        • et al.
        Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs.
        Gastrointest Endosc. 2003; 57: 17-22
        • Triadafilopoulos G.
        Changes in gerd symptom scores correlate with improvement in esophageal acid exposure after the Stretta procedure.
        Surg Endosc. 2004; 18: 1038-1044
        • Arts J.
        • Bisschops R.
        • Blondeau K.
        • et al.
        A double -blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD.
        Am J Gastroenerol. 2012; 107: 222-230
        • Corley D.A.
        • Katz P.
        • Wo J.M.
        • et al.
        Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham controlled trial.
        Gastroenerology. 2003; 125: 668-676
        • Coron E.
        • Sebille V.
        • Cadiot G.
        • et al.
        Clinical trial: radiofrequency energy delivery in proton pump inhibitor dependent gastro-oesopheal reflux disease patients.
        Aliment Pharmacol Ther. 2008; 28: 1147-1158
        • Abdel Aziz A.M.
        • El-Khayat H.R.
        • Sadek A.
        • et al.
        A prospective randomized trial of sham, single-dose stretta, and double-dose Stretta for the treatment of gastroesopheal reflux disease.
        Surg Endosc. 2010; 24: 818-825
        • Kalapala R.
        • Shah H.
        • Nabi Z.
        • et al.
        Treatment of gastroesophageal reflux disease using radiofrequency ablation (stretta procedure): an interim analysis of a randomized trial.
        Indian J Gastroenterol. 2017; 36: 337-342
        • Zerbib F.
        • Sacher-Huvelin S.
        • Coron E.
        • et al.
        Randomized clinical trial: oesophageal radiofrequencey energy delivery versus sham for PPI-refractory heartburn.
        Aliment Pharmacol Ther. 2020; 52: 637-645
        • Perry K.A.
        • Banerjee A.
        • Melvin W.S.
        Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis.
        Surg Laparosc Endosc Percutan Tech. 2012; 22: 283-288
        • Lipka S.
        • Kumar A.
        • Richter J.E.
        No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis.
        Clin Gastroenterol Hepatol. 2015; 13: 1058-1067
        • Fass R.
        • Cahn F.
        • Scotti D.
        • et al.
        Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease.
        Surg Endosc. 2017; 31: 4865-4882
        • Xie P.
        • Yan J.
        • Ye L.
        • et al.
        Efficacy of different endoscopic treatments in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis.
        Surg Endosc. 2012; 35: 1500-1510
        • Dughera l
        • Rotondano G.
        • De Cento M.
        • et al.
        Durability of Stretta Radiofrequency treatment for GERD: results of an 8-year follow-up.
        Gastroenterol Res Pract. 2014; 2014: 531907
        • Noar M.
        • Squires P.
        • Noar E.
        • et al.
        Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later.
        Surg Endosc. 2014; 28: 2323-2333
        • Reymunde A.
        • Santiago N.
        Long-term results of radiofrequency energy delivery for the treatmtn of GERD: sustained improvement in symptoms, quality of life and drug use at 4-year follow-up.
        Gastrointest Endosc. 2007; 65: 361-366
        • Reymunde A Santiago N.
        Fifteen plus years after stretta antireflux endoscopy procedure: quality of life and ppi requirements.
        Am J Gastroenterol. 2017; 112: ps459-ps460
        • Noar M.
        • Squires P.
        • Khan S.
        Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort.
        Surg Endosc. 2017; 31: 2854-2862
        • Ihde G.M.
        The evolution of TIF: transoral incisionless fundoplication.
        Therap Adv Gastroenterol. 2020; 13 (1756284820924206)
        • Bell R.C.
        • Barnes W.E.
        • Carter B.J.
        • et al.
        Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study.
        Am Surg. 2014; 80: 1093-1105
        • Chimukangara M.
        • Jalilvand A.D.
        • Melvin W.S.
        • et al.
        Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.
        Surg Endosc. 2019; 33: 1304-1309
        • Testoni P.A.
        • Testoni S.
        • Mazzoleni G.
        • et al.
        Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
        Surg Endosc. 2015; 29: 2770-2780
        • Repici A.
        • Fumagalli U.
        • Malesci A.
        • et al.
        Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience.
        J Gastrointest Surg. 2010; 14: 1-6
        • Velanovich V.
        Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned.
        Surgery. 2010; 148 ([discussion: 651-643]): 646-651
        • DeMeester T.R.
        • Wernly J.A.
        • Bryant G.H.
        • et al.
        Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery.
        Am J Surg. 1979; 137: 39-46
        • Patti M.G.
        • Allaix M.E.
        • Fisichella P.M.
        Analysis of the causes of failed antireflux surgery and the principles of treatment: a review.
        JAMA Surg. 2015; 150: 585-590
        • Barnes W.E.
        • Hoddinott K.M.
        • Mundy S.
        • et al.
        Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice.
        Surg Innov. 2011; 18: 119-129
        • Demyttenaere S.V.
        • Bergman S.
        • Pham T.
        • et al.
        Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population.
        Surg Endosc. 2010; 24: 854-858
        • Reavis K.M.
        • Perry K.A.
        Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.
        Expert Rev Med Devices. 2014; 11: 341-350
        • Horgan S.
        • Pellegrini C.A.
        Surgical treatment of gastroesophageal reflux disease.
        Surg Clin North Am. 1997; 77: 1063-1082
        • Testoni P.A.
        • Corsetti M.
        • Di Pietro S.
        • et al.
        Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.
        World J Surg. 2010; 34: 750-757
        • Ihde G.M.
        • Besancon K.
        • Deljkich E.
        Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease.
        Am J Surg. 2011; 202 ([discussion: 746-747]): 740-746
        • Janu P.
        • Shughoury A.B.
        • Venkat K.
        • et al.
        Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
        Surg Innov. 2019; 26: 675-686
        • Trad K.S.
        • Barnes W.E.
        • Prevou E.R.
        • et al.
        The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
        Surg Innov. 2018; 25: 149-157
        • Trad K.S.
        • Simoni G.
        • Barnes W.E.
        • et al.
        Transoral Fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with crossover arm.
        Surg Endosc. 2017; 31: 2498-2508
        • Trad K.S.
        • Simoni G.
        • Barnes W.E.
        • et al.
        PG Mavrelis Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open-label, crossover study.
        BMC Gastroenterol. 2014; 14: 174
        • Trad K.S.
        • Barnes W.E.
        • Simoni G.
        • et al.
        Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial.
        Surg Innov. 2015; 22: 26-40
        • Bell R.C.
        • Mavrelis P.G.
        • Barnes W.E.
        • et al.
        A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
        J Am Coll Surg. 2012; 215: 794-809
        • Bell R.C.
        • Fox M.A.
        • Barnes W.E.
        • et al.
        Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication.
        Surg Endosc. 2014; 28: 2949-2958
        • Wilson E.B.
        • Barnes W.E.
        • Mavrelis P.G.
        • et al.
        The Effects of Transoral Incisionless Fundoplication on Chronic GERD Patients: 12-Month Prospective Multicenter Experience.
        Surg Laparosc Endosc Percutan Tech. 2014; 24: 36-46
        • Hunter J.G.
        • Kahrilas P.J.
        • Bell R.C.
        • et al.
        Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.
        Gastroenterology. 2015; 148: 324-333.e5
        • Hakansson B.
        • Montgomery M.
        • Cadiere G.B.
        • et al.
        Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.
        Aliment Pharmacol Ther. 2015; 42: 1261-1270
        • Huang X.
        • Chen S.
        • Zhao H.
        • et al.
        Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.
        Surg Endosc. 2017; 31: 1032-1044
        • Furnee E.J.
        • Broeders J.A.
        • Draaisma W.A.
        • et al.
        Laparoscopic Nissen fundoplication after failed EsophyX fundoplication.
        Br J Surg. 2010; 97: 1051-1055
        • Bell R.C.
        • Kurian A.A.
        • Freeman K.D.
        Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effective.
        Surg Endosc. 2015; 29: 1746-1752
        • Puri R.
        • Smith C.D.
        • Bowers S.P.
        The spectrum of surgical remediation of transoral incisionless fundoplication-related failures.
        J Laparoendosc Adv Surg Tech A. 2018; 28: 1089-1093
        • Chang K.J.
        • Bell R.
        Transoral incisionless fundoplication.
        Gastrointest Endosc Clin N Am. 2020; 30: 267-289
        • Ramai D.
        • Shapiro A.
        • Barakat M.
        • et al.
        Adverse events associated with transoral incisionless fundoplication (TIF) for chronic gastroesophageal reflux disease: a MAUDE database analysis.
        Surg Endosc. 2021;
        • Rabach L.
        • Saad A.R.
        • Velanovich V.
        How to choose among fundoplication, magnetic sphincter augmentation or transoral incisionless fundoplication.
        Curr Opin Gastroenterol. 2019; 35: 371-378
        • Yamasaki T.
        • Hemond C.
        • Eisa M.
        • et al.
        The changing epidemiology of gastroesophageal reflux disease: are patients getting younger?.
        J Neurogastroenterology Motil. 2018; 24: 559-569
        • Katz P.
        • Dunbar K.
        • Schnoll-Sussman F.
        • et al.
        ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease.
        Am J Gastroenterol. 2022; 117: 27-56
        • Sumi K.
        • Inoue H.
        • Kobayashi Y.
        • et al.
        Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
        Dig Endosc. 2021; 33: 347-354
        • Rodriguez de Santiago E.
        • Albeniz E.
        • Estremera-Arevalo F.
        • et al.
        Endoscopic anti-reflux therapy for gastroesophageal reflux disease.
        World J Gastroenterol. 2021; 27: 6601-6615
        • Monino L.
        • Gonzalez J.M.
        • Vitton V.
        • et al.
        Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control.
        Endosc Int Open. 2020; 8: E147-E154
        • Hedberg H.
        • Kuchta K.
        • Ujiki M.
        First experience with banded anti-reflux mucosectomy (arms) for gerd: feasibility, safety, and technique.
        J Gastrointest Surg. 2019; 23: 1274-1278
        • Yoo I.
        • Ko W.
        • Kim H.
        • et al.
        Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.
        Surg Endosc. 2020; 34: 1124-1131
        • Yang X.
        • Tan J.
        • Liu Y.
        • et al.
        Comparison of 180° anti-reflux mucosectomy versus 270° anti-reflux mucosectomy for treatment of refractory gastroesophageal reflux disease: a retrospective study.
        Surg Endosc. 2021;
        • Debourdeau A.
        • Vitton V.
        • Monino L.
        • et al.
        Antireflux Mucosectomy Band (ARM-b) in treatment of refractory gastroesophageal reflux disease after bariatric surgery.
        Obes Surg. 2020; 30: 4654-4658
        • Inouel H.
        • Tanabe M.
        • de Santiago E.R.
        • et al.
        Anti-reflux mucosal ablation (ARMS) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study.
        Endosc Int Open. 2020; 8: 133-138
        • Wong H.
        • Su B.
        • Attaar M.
        • et al.
        Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication.
        Surg Endosc. 2020;